Gene therapy for the treatment of bone and soft tissue tumors
基因疗法治疗骨和软组织肿瘤
基本信息
- 批准号:15390456
- 负责人:
- 金额:$ 9.47万
- 依托单位:
- 依托单位国家:日本
- 项目类别:Grant-in-Aid for Scientific Research (B)
- 财政年份:2003
- 资助国家:日本
- 起止时间:2003 至 2005
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Gene therapy for the treatment of bone and soft tissue tumors was studied in vitro and in vivo using cell culture and an experimental animal model developed originally. Lung metastases of osteosarcoma were inhibited markedly by addition of thymidine kinase gene of herpes simplex virus followed by anti-virus agent. Growth of bone metastasis due to breast cancer was also inhibited by suicide gene therapy. Decorin, small leucin-rich proteoglycan family, was identified as lung metastasis-related gene in osteosarcoma by differential gene expression methods. Lung metastasis of ostesarcoma cells transfected decorin gene were inhibited significantly in an animal model.In 31 high grade soft tissue sarcomas higher expression decorin by immunohistochemical staining showed better prognosis.These results suggest that gene therapy is useful for the treatment of bone and soft tissue tumors and their lung metastasis.
利用细胞培养和最初开发的实验动物模型,在体外和体内研究了用于治疗骨和软组织肿瘤的基因治疗。单纯疱疹病毒胸苷激酶基因联合抗病毒药物对骨肉瘤肺转移有明显的抑制作用。自杀基因治疗也抑制了乳腺癌骨转移的生长。核心蛋白聚糖(Decorin)是一个富含亮氨酸的蛋白聚糖家族,通过基因表达差异分析,确定其为骨肉瘤肺转移相关基因。在动物模型中,转染decorin基因的骨肉瘤细胞肺转移明显受到抑制,在31例高级别软组织肉瘤中,免疫组化染色显示decorin基因高表达者预后较好,提示基因治疗可用于骨和软组织肿瘤及其肺转移的治疗。
项目成果
期刊论文数量(28)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
New cell lines chondrocytic phenotypes from human chondrosarcoma
来自人类软骨肉瘤的新细胞系软骨细胞表型
- DOI:
- 发表时间:2004
- 期刊:
- 影响因子:0
- 作者:Kudawara I;Araki N;Myoui A;Kato Y;Uchida A;et al.
- 通讯作者:et al.
Case report : Case of clear cell sarcoma surviving with the primary lesion for 20 years afterresection of a metastatic lymph node
病例报告:透明细胞肉瘤切除转移淋巴结后原发病灶存活 20 年的病例
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Okamura N;Kusuzaki K;Matsumine A;Uchida A. et al.
- 通讯作者:Uchida A. et al.
Tenascin-C levels in pseudosynovial fluid of loose hip prosthesis
松动髋关节假体假滑液中腱蛋白-C 的水平
- DOI:
- 发表时间:2005
- 期刊:
- 影响因子:0
- 作者:Hasegawa M;Uchida A;et al.
- 通讯作者:et al.
Hasegawa M, Sudo A, Hirata H, Uchida A: "Ceramic acetabular liner fracture in total hip arthroplasty with a ceramic sandwich cup"J Arthroplasty. 18. 658-661 (2003)
Hasekawa M、Sudo A、Hirata H、Uchida A:“陶瓷夹心杯全髋关节置换术中的陶瓷髋臼内衬骨折”J 关节成形术。
- DOI:
- 发表时间:
- 期刊:
- 影响因子:0
- 作者:
- 通讯作者:
Case report : Recurrence of soft tissue MFH in bone due to minute intravenous tumor emboli detected by MRI
病例报告 : MRI 检测到微小静脉肿瘤栓塞导致骨内软组织 MFH 复发
- DOI:
- 发表时间:2003
- 期刊:
- 影响因子:0
- 作者:Nakamura T;Kusuzaki K;Seto M;Matsumine A;Uchida A
- 通讯作者:Uchida A
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
UCHIDA Atsumasa其他文献
UCHIDA Atsumasa的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('UCHIDA Atsumasa', 18)}}的其他基金
Biology-based management in metastatic bone tumors
转移性骨肿瘤的生物学治疗
- 批准号:
18390412 - 财政年份:2006
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Gene therapy for the treatment of chondrosarcoma
软骨肉瘤的基因疗法
- 批准号:
12470306 - 财政年份:2000
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Study of pathogenesis and treatment in metastatic bone disease
骨转移病发病机制及治疗研究
- 批准号:
09470313 - 财政年份:1997
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
相似海外基金
Exploration novel effects of SHED-TK-derived exosomes on TK/GCV suicide gene therapy
探索SHED-TK衍生的外泌体对TK/GCV自杀基因治疗的新作用
- 批准号:
23K15643 - 财政年份:2023
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Engineering ERK-specificity for cancer suicide gene therapy
工程 ERK 特异性用于癌症自杀基因治疗
- 批准号:
10044569 - 财政年份:2020
- 资助金额:
$ 9.47万 - 项目类别:
Suicide gene therapy using mesenchymal stem cells for brain tumors
使用间充质干细胞治疗脑肿瘤的自杀基因疗法
- 批准号:
19K09504 - 财政年份:2019
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Suicide gene therapy for malignant glioma using genome-edited human induced pluripotent stem cells
使用基因组编辑的人类诱导多能干细胞治疗恶性神经胶质瘤的自杀基因治疗
- 批准号:
19K16872 - 财政年份:2019
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Development of polymeric micelles for photothermal/suicide gene therapy combined with immune checkpoint blockage
开发用于光热/自杀基因治疗并结合免疫检查点阻断的聚合物胶束
- 批准号:
18F18368 - 财政年份:2018
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of cancer suicide gene therapy using RNA trans-splicing technology
利用RNA转拼技术开发癌症自杀基因疗法
- 批准号:
17K19475 - 财政年份:2017
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Development of retroviral replicating vector-mediated suicide gene therapy for malignant mesothelioma
逆转录病毒复制载体介导的恶性间皮瘤自杀基因疗法的发展
- 批准号:
16K10484 - 财政年份:2016
- 资助金额:
$ 9.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
用于复发性卵巢癌自杀基因治疗的纳米技术平台
- 批准号:
8815552 - 财政年份:2015
- 资助金额:
$ 9.47万 - 项目类别:
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
用于复发性卵巢癌自杀基因治疗的纳米技术平台
- 批准号:
9042994 - 财政年份:2015
- 资助金额:
$ 9.47万 - 项目类别:
A Nanotechnology Platform for Suicide Gene Therapy of Recurring Ovarian Cancer
用于复发性卵巢癌自杀基因治疗的纳米技术平台
- 批准号:
9248338 - 财政年份:2015
- 资助金额:
$ 9.47万 - 项目类别: